From Drew Altman June 21, 2024 Page From Drew Altman Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the…
What are the Recent Trends in Employer-Based Health Coverage? December 22, 2023 Issue Brief This chart collection presents analysis of data from recent Annual Economic and Social Supplements (ASEC) of the Current Population Survey (CPS) to examine who among non-elderly people has employer-sponsored insurance and which workers are offered and eligible for coverage at their current jobs.
Insurer Strategies to Control Costs Associated with Weight Loss Drugs June 12, 2024 Issue Brief Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a an analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription…
What are the Trends in Health Utilization and Spending in Early 2024? August 20, 2024 Issue Brief Recent trends in healthcare utilization and spending suggest that most spending on health services exceeds pre-pandemic levels and health costs are growing at a faster rate than in recent years. However, utilization of care has been uneven by setting and market. For example, some measures of hospital utilization remain lower…
How Many People with Employer-Sponsored Insurance Use the Drugs Slated for Medicare Price Negotiations August 14, 2024 Issue Brief Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis. The most used drug for people with employer-sponsored health insurance was Jardiance, a drug used to treat diabetes and…
Hagere Yilma May 30, 2023 Person Hagere Yilma is the senior manager of the Health Misinformation and Trust Initiative at KFF. In this role, Yilma is developing a new program aimed at combatting health misinformation and fostering trust in news and media. Previously, Yilma collaborated with global organizations, including the World Health Organization and the World…
Irving Washington December 5, 2022 Person Irving Washington is senior vice president and executive director of the Health Misinformation and Trust Initiative at KFF, where he leads a new initiative focused on identifying health misinformation to improve understanding of critical health news and research and build trust among communities. Before joining KFF, Washington was the CEO…
What the FTC’s New Protections From Non-Compete Agreements Mean in a Mostly Non-Profit Hospital Industry July 24, 2024 Blog This analysis uses 2022 data from the American Hospital Association (AHA) Annual Survey Database to present the number and share of hospital workers by occupation who may not be covered by the federal protections against non-compete agreements because they work for a non-profit hospital.
The Health Misinformation Monitor: AI Chatbots as Health Information Sources August 22, 2024 Page In this issue, we take a closer look at the reliability of artificial intelligence (AI) chatbots as a source of health information. We explore public opinion on chatbot accuracy based on KFF surveys and highlight recent examples of AI-generated election misinformation in the news. In addition, we share our firsthand experience querying AI chatbots on health topics and discuss research on gaps in safeguards.